SNCA and Parkinson disease: The interaction between alpha-synuclein and tyrosinase may occur more frequently in patients with PD who have shortage in dopamine levels, and the fibrillar forms of alpha-synuclein within PD disease may be responsible for impairments within the tyrosine pathway involved in melanogenesis, predisposing the individual to melanoma [19].